Company / Capital Expenditures
AIM ImmunoTech Inc. Capital Expenditures History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$18.0K
FY2024
5-year range
$18.0K / $86.0K
FY2020-FY2024
Trend
-79.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures has fluctuated over the past 9 years, ranging from $18,000 in FY2024 to $240,000 in FY2017.
Based on SEC 10-K filings.
$18,000 in FY2024 with a 5-year CAGR of -23.3%.
Declined from $41,000 to $18,000 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -6.5%
- 5-Year CAGR
- -23.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -23.3%, indicating a declining trend.
- In FY2024, capital expenditures decreased 79.1% year-over-year.
- Peak capital expenditures was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score -71.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $18.0K | -79.1% |
| FY2023 | $86.0K | +109.8% |
| FY2022 | $41.0K | +86.4% |
| FY2021 | $22.0K | +0.0% |
| FY2020 | $22.0K | -67.6% |
| FY2019 | $68.0K | +33.3% |
| FY2018 | $51.0K | -78.8% |
| FY2017 | $240.0K | +50.0% |
| FY2016 | $160.0K | -33.3% |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026